Trial Profile
Pilot Study of the Effect of Pegaptanib Sodium to Prevent Worsening of Cystoid Macular Edema Following Cataract Surgery in Diabetics
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 07 Dec 2015 New trial record